| Identification | Back Directory | [Name]
Oxo Enzalutamide | [CAS]
1242137-18-3 | [Synonyms]
Oxo Enzalutamide
4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide
Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-2,4-dioxo-1-imidazolidinyl]-2-fluoro-N-methyl- | [Molecular Formula]
C21H16F4N4O3 | [MDL Number]
MFCD34471735 | [MOL File]
1242137-18-3.mol | [Molecular Weight]
448.37 |
| Hazard Information | Back Directory | [Uses]
Oxo-MDV 3100 (Oxo-enzalutamide) is an impurity of Enzalutamide (M199800), which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer. |
|
|